159 related articles for article (PubMed ID: 37958846)
41. Molecular mechanisms of HIF-1alpha modulation induced by oxygen tension and BMP2 in glioblastoma derived cells.
Pistollato F; Rampazzo E; Abbadi S; Della Puppa A; Scienza R; D'Avella D; Denaro L; Te Kronnie G; Panchision DM; Basso G
PLoS One; 2009 Jul; 4(7):e6206. PubMed ID: 19587783
[TBL] [Abstract][Full Text] [Related]
42. Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells.
De Robertis A; Valensin S; Rossi M; Tunici P; Verani M; De Rosa A; Giordano C; Varrone M; Nencini A; Pratelli C; Benicchi T; Bakker A; Hill J; Sangthongpitag K; Pendharkar V; Liu B; Ng FM; Then SW; Jing Tai S; Cheong SM; He X; Caricasole A; Salerno M
Mol Cancer Ther; 2013 Jul; 12(7):1180-9. PubMed ID: 23619303
[TBL] [Abstract][Full Text] [Related]
43. Class III beta-tubulin and gamma-tubulin are co-expressed and form complexes in human glioblastoma cells.
Katsetos CD; Dráberová E; Smejkalová B; Reddy G; Bertrand L; de Chadarévian JP; Legido A; Nissanov J; Baas PW; Dráber P
Neurochem Res; 2007 Aug; 32(8):1387-98. PubMed ID: 17406983
[TBL] [Abstract][Full Text] [Related]
44. Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.
Nitta RT; Gholamin S; Feroze AH; Agarwal M; Cheshier SH; Mitra SS; Li G
Oncogene; 2015 Jul; 34(28):3688-99. PubMed ID: 25241897
[TBL] [Abstract][Full Text] [Related]
45. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
[TBL] [Abstract][Full Text] [Related]
46. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
47. ATP-site binding inhibitor effectively targets mTORC1 and mTORC2 complexes in glioblastoma.
Neil J; Shannon C; Mohan A; Laurent D; Murali R; Jhanwar-Uniyal M
Int J Oncol; 2016 Mar; 48(3):1045-52. PubMed ID: 26719046
[TBL] [Abstract][Full Text] [Related]
48. Establishment and partial characterization of a human tumor cell line, GBM-HSF, from a glioblastoma multiforme.
Qu J; Rizak JD; Fan Y; Guo X; Li J; Huma T; Ma Y
Hum Cell; 2014 Jul; 27(3):129-36. PubMed ID: 24390806
[TBL] [Abstract][Full Text] [Related]
49. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
[TBL] [Abstract][Full Text] [Related]
50. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
[TBL] [Abstract][Full Text] [Related]
51. Characterization of adherent primary cell lines from fresh human glioblastoma tissue, defining glial fibrillary acidic protein as a reliable marker in establishment of glioblastoma cell culture.
Grube S; Freitag D; Kalff R; Ewald C; Walter J
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1324. PubMed ID: 33251771
[TBL] [Abstract][Full Text] [Related]
52. Molecular Crosstalk between T Cells and Tumor Uncovers GBM-Specific T Cell Signatures in Blood: Noninvasive GBM Diagnosis Using Immunosensors.
Dhinakaran AK; Dharmalingam P; Ganesh S; Venkatakrishnan K; Das S; Tan B
ACS Nano; 2022 Sep; 16(9):14134-14148. PubMed ID: 36040842
[TBL] [Abstract][Full Text] [Related]
53. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
[TBL] [Abstract][Full Text] [Related]
54. PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells.
Udawant S; Litif C; Lopez A; Gunn B; Schuenzel E; Keniry M
Cells; 2021 Nov; 10(11):. PubMed ID: 34831287
[TBL] [Abstract][Full Text] [Related]
55. Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy.
Rose M; Cardon T; Aboulouard S; Hajjaji N; Kobeissy F; Duhamel M; Fournier I; Salzet M
Front Immunol; 2021; 12():746168. PubMed ID: 34646273
[TBL] [Abstract][Full Text] [Related]
56. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.
Luo D; Fraga-Lauhirat M; Millings J; Ho C; Villarreal EM; Fletchinger TC; Bonfiglio JV; Mata L; Nemesure MD; Bartels LE; Wang R; Rigas B; Mackenzie GG
Carcinogenesis; 2019 Dec; 40(12):1480-1491. PubMed ID: 30994173
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma.
Li W; Liu Y; Yang W; Han X; Li S; Liu H; Gerweck LE; Fukumura D; Loeffler JS; Yang BB; Jain RK; Huang P
J Neurooncol; 2018 Jan; 136(1):63-71. PubMed ID: 29081036
[TBL] [Abstract][Full Text] [Related]
58. Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines.
Binder ZA; Wilson KM; Salmasi V; Orr BA; Eberhart CG; Siu IM; Lim M; Weingart JD; Quinones-Hinojosa A; Bettegowda C; Kassam AB; Olivi A; Brem H; Riggins GJ; Gallia GL
PLoS One; 2016; 11(3):e0150271. PubMed ID: 27028405
[TBL] [Abstract][Full Text] [Related]
59. C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells.
Manzano S; Gutierrez-Uzquiza A; Bragado P; Sequera C; Herranz Ó; Rodrigo-Faus M; Jauregui P; Morgner S; Rubio I; Guerrero C; Porras A
Cell Death Dis; 2021 Apr; 12(4):348. PubMed ID: 33824275
[TBL] [Abstract][Full Text] [Related]
60. The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin.
Peng G; Wang Y; Ge P; Bailey C; Zhang P; Zhang D; Meng Z; Qi C; Chen Q; Chen J; Niu J; Zheng P; Liu Y; Liu Y
J Exp Clin Cancer Res; 2021 Sep; 40(1):278. PubMed ID: 34470658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]